← Product Code [KLE](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/KLE) · K150164 # Monobond Etch & Prime (K150164) _Ivoclar Vivadent, AG · KLE · Apr 3, 2015 · Dental · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/KLE/K150164 ## Device Facts - **Applicant:** Ivoclar Vivadent, AG - **Product Code:** [KLE](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/KLE.md) - **Decision Date:** Apr 3, 2015 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.3200 - **Device Class:** Class 2 - **Review Panel:** Dental ## Indications for Use Conditioning of silica-based ceramic surfaces for the adhesive bond with luting composites ## Device Story Monobond Etch & Prime is a dental conditioning agent used extra-orally by dental technicians to prepare silica-based ceramic surfaces for bonding with luting composites. It functions as a single-step solution that combines etching and silanization, replacing the traditional separate step of etching with 5% hydrofluoric acid. The device contains silane, a ceramic etching agent, and adhesive monomers. By eliminating the need for separate hydrofluoric acid etching, the device simplifies the preparation process for silica glass ceramics. The healthcare provider applies the agent to the ceramic surface to enable subsequent bonding with luting composites (e.g., Variolink or Multilink lines). The device benefits the patient by ensuring a reliable adhesive bond for ceramic restorations. ## Clinical Evidence Bench testing only. Tensile bond strength testing was performed to compare the subject device to the predicate. Results demonstrated that the performance of Monobond Etch & Prime conforms to specifications and is substantially equivalent to the predicate. Biocompatibility was assessed according to EN ISO 10993-1:2009 and EN ISO 7405:2008. ## Technological Characteristics Liquid solution containing silane, ceramic etching agent, and adhesive monomers. Applied extra-orally. Tested per ISO 1641:2009. Biocompatibility tested per EN ISO 10993-1:2009 and EN ISO 7405:2008. No software or electronic components. ## Regulatory Identification A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling. ## Predicate Devices - Monobond Plus ([K090826](/device/K090826.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a symbol consisting of three stylized human profiles facing to the right, with flowing lines beneath them. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 April 3, 2015 Ivoclar Vivadent, Inc. Ms. Donna Marie Hartnett, Esq. Director, QA/Regulatory Affairs 175 Pineview Drive Amherst, NY 14228 Re: K150164 Trade/Device Name: Monobond® Etch & Prime Regulation Number: 21 CFR 872.3200 Regulation Name: Resin Tooth Bonding Agent Regulatory Class: II Product Codes: KLE Dated: January 21, 2015 Received: January 26, 2015 Dear Ms. Hartnett: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Isting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ ### Page 2 - Ms. Donna Marie Hartnett Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. Tina Kiang-S for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K150164 Device Name MONOBOND ETCH & PRIME Indications for Use (Describe) Conditioning of silica-based ceramic surfaces for the adhesive bond with luting composites | Type of Use (Select one or both, as applicable) | | |-------------------------------------------------|--| |-------------------------------------------------|--| > Prescription Use (Part 21 CFR 801 Subpart D) _ Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/1 description: The image shows the logo for Ivoclar Vivadent. The logo consists of the company name in blue, with the word "Ivoclar" stacked on top of "Vivadent". Below the name is the slogan "passion vision innovation" in red. Above the company name is a curved line of green and blue squares and circles. | Contact: | Donna Marie Hartnett | |----------------------|----------------------------------------------------------------------------------------------| | Company: | Ivoclar Vivadent, AG
Bendererstrasse 2, Schaan
FL-9494, Liechtenstein
+423-235-3535 | | Date Prepared: | February 10, 2015 | | Proprietary Name: | Monobond® Etch & Prime | | Classification Name: | Agent, Tooth bonding, Resin (872.3200)
(Classification Code KLE) | | Predicate Device: | Monobond Plus (K090826) | Device Description: Monobond Etch & Prime is used to condition silica-based ceramic surfaces for the adhesive bond with luting composites from the Variolink or Multilink product lines, for example, Monobond Etch & Prime etches and silanizes silicate ceramic suffaces in one working step. The new product combines the role of bonding agent with that of etchant. Typically the dental technician would etch the ceramic with 5% hydrofluoric acid but this step is achieved using Monobond Etch & Prime. The etching step was carried out outside the mouth and the new product is also limited to extra-oral applications of the new product are limited to silica ceramics, Oxide ceramics, metal, composite and fibre-reinforced composites are not indicated. This is because only silica glass ceramics required etching with hydrofluoric acid and therefore the benefit of using Monobond Etch & Prime is primarily relevant for this group of materials. ### Intended Use: Conditioning of silica-based ceramic surfaces for the adhesive bond with luting composites Comparison to Predicate: The predicate device to which Monobond Etch & Prime has been compared is Monobond Plus (K090826). For this application, Monobond Etch & Prime has been compared to its predicate with regard to chemical composition, physical properties, and indications for use. The comparison shows that Monobond Etch & Prime is substantially equivalent to the predicate device. {4}------------------------------------------------ # 510(K) SUMMARY (rev 2.10.15) Monobond® Etch & Prime Image /page/4/Picture/1 description: The image is a logo for Ivoclar Vivadent. The logo features the company name in blue, with the word "Ivoclar" stacked on top of "Vivadent". Above the company name is an arc of green and blue dots. Below the company name is the phrase "passion vision innovation" in red. | Predicate - Monobond Plus (K090826) | Subject Device | |--------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Bonding agent between luting composites and glass/oxide ceramic, metal, composite and fiber-reinforced composite restorations. | Conditioning of silica-based ceramic surfaces for the adhesive bond with luting composites. | | Monobond Plus is a dilute solution of adhesive monomers and silane which enable it to be used with various substrates. | Monobond Etch & Prime is a dilute solution of silane, a ceramic etching agent and an adhesive monomer, and can be used only with silica ceramics | | Tensile bond strength to glass ceramics was tested for comparison purposes to the subject device. | Tensile bond strength testing showed that the performance of the subject device is conforming to the specification and substantially equivalent to the predicate device. | Technological Characteristics and Testing Summary: As no product specific standard exists for the subject device, testing was conducted under ISO 1641:2009 Dentistry - Medical Devices for dentistry - Materials. The device was tested for Tensile bond strength. The predicate referred to shear bond strength. The methods and specifications cannot be directly compared. However, tests for Monobond Etch & Prime and Monobond Plus tensile bond strength showed that the performance of the new product is conforming to the specification and substantially equivalent to the predicate. Only the bond strength to glass ceramics is considered as use with oxide ceramics is not indicated for Monobond Etch & Prime. The key function of Monobond Etch & Prime is to silanise silica glass ceramics. This is achieved using exactly the same silane agent as used in Monobond Plus. Although the compositions are different, the subject device has been assessed for biocompatibility through testing according EN ISO 10993-1:2009 and EN ISO 7405:2008. The device design, i.e. delivery form, and the predicate device are the same. They are both applied extra-orally. The Intended use of the subject and the predicate device are the same except that the subject device is limited for use with silica-based ceramic surfaces. This be because only silica glass ceramics require etching with hydrofluoric acid and therefore the benefit of using the subject device is relevant for this group of materials. CONCLUSION: The above data and analysis demonstrates that Monobond Etch & Prime is substantially equivalent to the predicate device. --- **Source:** [https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/KLE/K150164](https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/KLE/K150164) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com